160 related articles for article (PubMed ID: 30650251)
21. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
Carcinogenesis; 2019 Jul; 40(5):651-660. PubMed ID: 30715157
[TBL] [Abstract][Full Text] [Related]
22. Chemogenomics analysis of drug targets for the treatment of acute promyelocytic leukemia.
Chen S; Li X; Ma S; Xing X; Wang X; Zhu Z
Ann Hematol; 2020 Apr; 99(4):753-763. PubMed ID: 32016577
[TBL] [Abstract][Full Text] [Related]
23. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
[TBL] [Abstract][Full Text] [Related]
24. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
26. The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.
Wampfler J; Federzoni EA; Torbett BE; Fey MF; Tschan MP
Leuk Res; 2016 Feb; 41():96-102. PubMed ID: 26740055
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
28. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
29. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
30. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.
Foley R; Soamboonsrup P; Carter RF; Benger A; Meyer R; Walker I; Wan Y; Patterson W; Orzel A; Sunisloe L; Leber B; Neame PB
Am J Hematol; 2001 May; 67(1):34-41. PubMed ID: 11279655
[TBL] [Abstract][Full Text] [Related]
31. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.
Pagnano KB; Traina F; Takahashi T; Oliveira GB; Rossini MS; Lorand-Metze I; Vigorito AC; Miranda EC; De Souza CA
Sao Paulo Med J; 2000 Nov; 118(6):173-8. PubMed ID: 11120548
[TBL] [Abstract][Full Text] [Related]
32. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract][Full Text] [Related]
33. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
[TBL] [Abstract][Full Text] [Related]
34. The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patients.
Mitrovic M; Kostic T; Virijevic M; Karan-Djurasevic T; Suvajdzic Vukovic N; Pavlovic S; Tosic N
Int J Lab Hematol; 2020 Feb; 42(1):82-87. PubMed ID: 31830382
[TBL] [Abstract][Full Text] [Related]
35. In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival.
Nolte F; Hecht A; Reinwald M; Nowak D; Nowak V; Hanfstein B; Faldum A; Büchner T; Spiekermann K; Sauerland C; Hofmann WK; Lengfelder E
Leuk Res; 2013 Apr; 37(4):378-82. PubMed ID: 23287429
[TBL] [Abstract][Full Text] [Related]
36. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
[TBL] [Abstract][Full Text] [Related]
37. A convolutional neural network-based, quantitative complete blood count scattergram-mapping framework promptly screens acute promyelocytic leukemia with high sensitivity.
Liao H; Xu Y; Meng Q; Mao Z; Qiao Y; Liu Y; Zheng Q
Cancer; 2023 Oct; 129(19):2986-2998. PubMed ID: 37254628
[TBL] [Abstract][Full Text] [Related]
38. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
39. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
40. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
